Truvian Raises $105M, Plans to Submit Benchtop Blood-Testing Tech to FDA


Unlike Theranos, Truvian is seeking regulatory clearance from the outset, and bringing in laboratory experts to validate its approach. As it approaches its FDA submission, Truvian plans to ramp up clinical trials and manufacturing of cartridges for its device.